Total Payments
$87,600
2024 Payments
$959.64
Companies
36
Transactions
268
Medicare Patients
2,743
Medicare Billing
$645,568
Payment Breakdown by Category
Research$82,193 (93.8%)
Food & Beverage$5,407 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $82,193 | 2 | 93.8% |
| Food and Beverage | $5,407 | 266 | 6.2% |
Payments by Type
Research
$82,193
2 transactions
General
$5,407
266 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $82,193 | 2 | $0 (2022) |
| Novo Nordisk Inc | $1,142 | 50 | $0 (2024) |
| ABBVIE INC. | $520.92 | 34 | $0 (2024) |
| Lilly USA, LLC | $434.20 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $428.78 | 19 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $416.45 | 16 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $214.69 | 15 | $0 (2024) |
| Amarin Pharma Inc. | $209.18 | 10 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $206.41 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $182.32 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $959.64 | 43 | Lilly USA, LLC ($212.70) |
| 2023 | $1,226 | 59 | AstraZeneca Pharmaceuticals LP ($288.36) |
| 2022 | $76,861 | 57 | Eli Lilly and Company ($75,693) |
| 2021 | $8,079 | 83 | Eli Lilly and Company ($6,500) |
| 2020 | $458.13 | 25 | Allergan, Inc. ($158.83) |
| 2019 | $16.17 | 1 | GlaxoSmithKline, LLC. ($16.17) |
All Payment Transactions
268 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: NEUROLOGY | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 09/26/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardio-renal | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $31.32 | General |
| Category: Insulin Pump | ||||||
| 07/29/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Gastroenterology | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Cardio-renal | ||||||
| 06/10/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Medical Device | ||||||
| 06/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) | Eli Lilly and Company | $82,193 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,310 | 3,223 | $437,268 | $277,524 |
| 2022 | 13 | 968 | 2,790 | $399,755 | $231,247 |
| 2021 | 10 | 465 | 1,476 | $233,805 | $136,797 |
Total Patients
2,743
Total Services
7,489
Medicare Billing
$645,568
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 252 | 769 | $115,350 | $74,849 | 64.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 226 | 864 | $86,400 | $56,506 | 65.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 197 | 247 | $59,280 | $34,909 | 58.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 308 | $46,200 | $27,660 | 59.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 53 | 282 | $33,840 | $24,502 | 72.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 56 | 279 | $25,110 | $16,856 | 67.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 107 | 136 | $20,400 | $12,742 | 62.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 58 | $18,270 | $10,250 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 100 | $11,000 | $6,581 | 59.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $5,280 | $4,409 | 83.5% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 43 | 52 | $7,800 | $3,455 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $2,925 | $1,676 | 57.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $3,360 | $1,557 | 46.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 24 | 47 | $1,645 | $1,247 | 75.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $408.00 | $324.53 | 79.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 286 | 1,253 | $187,950 | $103,576 | 55.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 230 | 280 | $67,200 | $44,466 | 66.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 171 | 626 | $62,600 | $35,874 | 57.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 28 | 152 | $18,240 | $10,824 | 59.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 55 | $17,325 | $9,695 | 56.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 57 | 71 | $10,650 | $5,978 | 56.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 23 | 106 | $9,540 | $5,849 | 61.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 90 | $9,900 | $5,611 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 61 | $9,150 | $5,548 | 60.6% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 24 | 30 | $4,500 | $2,089 | 46.4% |
About Dr. Peter Haddad, M.D
Dr. Peter Haddad, M.D is a Internal Medicine healthcare provider based in Pasadena, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1033644299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Haddad, M.D has received a total of $87,600 in payments from pharmaceutical and medical device companies, with $959.64 received in 2024. These payments were reported across 268 transactions from 36 companies. The most common payment nature is "" ($82,193).
As a Medicare-enrolled provider, Haddad has provided services to 2,743 Medicare beneficiaries, totaling 7,489 services with total Medicare billing of $645,568. Data is available for 3 years (2021–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pasadena, TX
- Active Since 04/25/2017
- Last Updated 09/04/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1033644299
Products in Payments
- Ozempic (Drug) $605.47
- Kerendia (Drug) $416.45
- DALVANCE (Drug) $404.86
- Rybelsus (Drug) $368.66
- FARXIGA (Drug) $367.04
- JARDIANCE (Drug) $319.67
- MOUNJARO (Drug) $237.05
- XIFAXAN (Drug) $214.69
- Vascepa (Drug) $209.18
- Cologuard Collection Kit (Device) $169.73
- LEQVIO (Drug) $164.75
- XARELTO (Drug) $155.24
- RYBELSUS (Drug) $143.61
- GVOKE PFS (Drug) $129.64
- UBRELVY (Drug) $87.45
- LINZESS (Drug) $71.17
- FFRct (Device) $66.44
- GRALISE (Drug) $64.60
- Aimovig (Biological) $63.09
- MYRBETRIQ (Drug) $57.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882
John Debeixedon, M D, M D
Internal Medicine — Payments: $50,465
Internal Medicine $50,465